| Performance Enhancement Professionals Llc | |
|
1255 S State St, Suite 7, Dover, DE 19901-6932 | |
| (302) 423-0236 | |
| Not Available |
| Full Name | Performance Enhancement Professionals Llc |
|---|---|
| Type | Facility |
| Speciality | Physical Therapist - Sports |
| Location | 1255 S State St, Dover, Delaware |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417361197 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2251S0007X | Physical Therapist - Sports | J1-0000429 (Delaware) | Primary |
| Provider Name | Glenn P Brown |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1114980877 PECOS PAC ID: 2264425289 Enrollment ID: I20071025000546 |
News Archive
Researchers have devised a new plan of attack against a group of deadly childhood brain cancers collectively called diffuse midline gliomas, including diffuse intrinsic pontine glioma, thalamic glioma and spinal cord glioma.
The Queensland Government has tightened pool safety laws and launched a pool safety education campaign. From now on all pool fences will have to comply with new safety requirements within five years. Safety inspections will be required if a property is sold or rented before then. This is the second phase of tough new pool laws. The laws also give safety inspectors greater powers of entry to undertake checks.
ART Advanced Research Technologies Inc. (ART) (TSX:ARA), a Canadian medical device company and a leader in optical molecular imaging products for the healthcare and pharmaceutical industries, is pleased to announce that Dr. Gregory Czarnota, MD, PhD, Radiation Oncologist at Odette Cancer Centre, Sunnybrook Health Sciences Centre, will be presenting SoftScan® clinical results from a breast cancer treatment monitoring study, at the IEEE Engineering in Medicine and Biology Society 31st Annual International Conference in Minneapolis, Minn.
A personalized tumor cell vaccine strategy targeting Myc oncogenes combined with checkpoint therapy creates an effective immune response that bypasses antigen selection and immune privilege, according to a pre-clinical study for neuroblastoma and melanoma.
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that Dr. Spyros Kalams will provide an update of interim immune responses and safety results from the HVTN 080 Phase I clinical study of Inovio's PENNVAX-B HIV DNA vaccine in a preventive setting.
› Verified 4 days ago
| Provider Name | Katherine Monahan |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1033480025 PECOS PAC ID: 9739349358 Enrollment ID: I20120319000730 |
News Archive
Researchers have devised a new plan of attack against a group of deadly childhood brain cancers collectively called diffuse midline gliomas, including diffuse intrinsic pontine glioma, thalamic glioma and spinal cord glioma.
The Queensland Government has tightened pool safety laws and launched a pool safety education campaign. From now on all pool fences will have to comply with new safety requirements within five years. Safety inspections will be required if a property is sold or rented before then. This is the second phase of tough new pool laws. The laws also give safety inspectors greater powers of entry to undertake checks.
ART Advanced Research Technologies Inc. (ART) (TSX:ARA), a Canadian medical device company and a leader in optical molecular imaging products for the healthcare and pharmaceutical industries, is pleased to announce that Dr. Gregory Czarnota, MD, PhD, Radiation Oncologist at Odette Cancer Centre, Sunnybrook Health Sciences Centre, will be presenting SoftScan® clinical results from a breast cancer treatment monitoring study, at the IEEE Engineering in Medicine and Biology Society 31st Annual International Conference in Minneapolis, Minn.
A personalized tumor cell vaccine strategy targeting Myc oncogenes combined with checkpoint therapy creates an effective immune response that bypasses antigen selection and immune privilege, according to a pre-clinical study for neuroblastoma and melanoma.
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that Dr. Spyros Kalams will provide an update of interim immune responses and safety results from the HVTN 080 Phase I clinical study of Inovio's PENNVAX-B HIV DNA vaccine in a preventive setting.
› Verified 4 days ago
| Provider Name | Robert Price |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1407105265 PECOS PAC ID: 5799935284 Enrollment ID: I20121018000091 |
News Archive
Researchers have devised a new plan of attack against a group of deadly childhood brain cancers collectively called diffuse midline gliomas, including diffuse intrinsic pontine glioma, thalamic glioma and spinal cord glioma.
The Queensland Government has tightened pool safety laws and launched a pool safety education campaign. From now on all pool fences will have to comply with new safety requirements within five years. Safety inspections will be required if a property is sold or rented before then. This is the second phase of tough new pool laws. The laws also give safety inspectors greater powers of entry to undertake checks.
ART Advanced Research Technologies Inc. (ART) (TSX:ARA), a Canadian medical device company and a leader in optical molecular imaging products for the healthcare and pharmaceutical industries, is pleased to announce that Dr. Gregory Czarnota, MD, PhD, Radiation Oncologist at Odette Cancer Centre, Sunnybrook Health Sciences Centre, will be presenting SoftScan® clinical results from a breast cancer treatment monitoring study, at the IEEE Engineering in Medicine and Biology Society 31st Annual International Conference in Minneapolis, Minn.
A personalized tumor cell vaccine strategy targeting Myc oncogenes combined with checkpoint therapy creates an effective immune response that bypasses antigen selection and immune privilege, according to a pre-clinical study for neuroblastoma and melanoma.
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that Dr. Spyros Kalams will provide an update of interim immune responses and safety results from the HVTN 080 Phase I clinical study of Inovio's PENNVAX-B HIV DNA vaccine in a preventive setting.
› Verified 4 days ago
| Provider Name | Jessica Alyn Clausen |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1962883223 PECOS PAC ID: 8426360322 Enrollment ID: I20150707001490 |
News Archive
Researchers have devised a new plan of attack against a group of deadly childhood brain cancers collectively called diffuse midline gliomas, including diffuse intrinsic pontine glioma, thalamic glioma and spinal cord glioma.
The Queensland Government has tightened pool safety laws and launched a pool safety education campaign. From now on all pool fences will have to comply with new safety requirements within five years. Safety inspections will be required if a property is sold or rented before then. This is the second phase of tough new pool laws. The laws also give safety inspectors greater powers of entry to undertake checks.
ART Advanced Research Technologies Inc. (ART) (TSX:ARA), a Canadian medical device company and a leader in optical molecular imaging products for the healthcare and pharmaceutical industries, is pleased to announce that Dr. Gregory Czarnota, MD, PhD, Radiation Oncologist at Odette Cancer Centre, Sunnybrook Health Sciences Centre, will be presenting SoftScan® clinical results from a breast cancer treatment monitoring study, at the IEEE Engineering in Medicine and Biology Society 31st Annual International Conference in Minneapolis, Minn.
A personalized tumor cell vaccine strategy targeting Myc oncogenes combined with checkpoint therapy creates an effective immune response that bypasses antigen selection and immune privilege, according to a pre-clinical study for neuroblastoma and melanoma.
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that Dr. Spyros Kalams will provide an update of interim immune responses and safety results from the HVTN 080 Phase I clinical study of Inovio's PENNVAX-B HIV DNA vaccine in a preventive setting.
› Verified 4 days ago
| Provider Name | Rachel C Daniels |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1093204935 PECOS PAC ID: 4880940444 Enrollment ID: I20180712000336 |
News Archive
Researchers have devised a new plan of attack against a group of deadly childhood brain cancers collectively called diffuse midline gliomas, including diffuse intrinsic pontine glioma, thalamic glioma and spinal cord glioma.
The Queensland Government has tightened pool safety laws and launched a pool safety education campaign. From now on all pool fences will have to comply with new safety requirements within five years. Safety inspections will be required if a property is sold or rented before then. This is the second phase of tough new pool laws. The laws also give safety inspectors greater powers of entry to undertake checks.
ART Advanced Research Technologies Inc. (ART) (TSX:ARA), a Canadian medical device company and a leader in optical molecular imaging products for the healthcare and pharmaceutical industries, is pleased to announce that Dr. Gregory Czarnota, MD, PhD, Radiation Oncologist at Odette Cancer Centre, Sunnybrook Health Sciences Centre, will be presenting SoftScan® clinical results from a breast cancer treatment monitoring study, at the IEEE Engineering in Medicine and Biology Society 31st Annual International Conference in Minneapolis, Minn.
A personalized tumor cell vaccine strategy targeting Myc oncogenes combined with checkpoint therapy creates an effective immune response that bypasses antigen selection and immune privilege, according to a pre-clinical study for neuroblastoma and melanoma.
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that Dr. Spyros Kalams will provide an update of interim immune responses and safety results from the HVTN 080 Phase I clinical study of Inovio's PENNVAX-B HIV DNA vaccine in a preventive setting.
› Verified 4 days ago
| Provider Name | Sydney Boyd |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1598245359 PECOS PAC ID: 0840542759 Enrollment ID: I20181003003790 |
News Archive
Researchers have devised a new plan of attack against a group of deadly childhood brain cancers collectively called diffuse midline gliomas, including diffuse intrinsic pontine glioma, thalamic glioma and spinal cord glioma.
The Queensland Government has tightened pool safety laws and launched a pool safety education campaign. From now on all pool fences will have to comply with new safety requirements within five years. Safety inspections will be required if a property is sold or rented before then. This is the second phase of tough new pool laws. The laws also give safety inspectors greater powers of entry to undertake checks.
ART Advanced Research Technologies Inc. (ART) (TSX:ARA), a Canadian medical device company and a leader in optical molecular imaging products for the healthcare and pharmaceutical industries, is pleased to announce that Dr. Gregory Czarnota, MD, PhD, Radiation Oncologist at Odette Cancer Centre, Sunnybrook Health Sciences Centre, will be presenting SoftScan® clinical results from a breast cancer treatment monitoring study, at the IEEE Engineering in Medicine and Biology Society 31st Annual International Conference in Minneapolis, Minn.
A personalized tumor cell vaccine strategy targeting Myc oncogenes combined with checkpoint therapy creates an effective immune response that bypasses antigen selection and immune privilege, according to a pre-clinical study for neuroblastoma and melanoma.
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that Dr. Spyros Kalams will provide an update of interim immune responses and safety results from the HVTN 080 Phase I clinical study of Inovio's PENNVAX-B HIV DNA vaccine in a preventive setting.
› Verified 4 days ago
| Provider Name | Nicholas Gruwell |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1801486857 PECOS PAC ID: 5092129106 Enrollment ID: I20210202000737 |
News Archive
Researchers have devised a new plan of attack against a group of deadly childhood brain cancers collectively called diffuse midline gliomas, including diffuse intrinsic pontine glioma, thalamic glioma and spinal cord glioma.
The Queensland Government has tightened pool safety laws and launched a pool safety education campaign. From now on all pool fences will have to comply with new safety requirements within five years. Safety inspections will be required if a property is sold or rented before then. This is the second phase of tough new pool laws. The laws also give safety inspectors greater powers of entry to undertake checks.
ART Advanced Research Technologies Inc. (ART) (TSX:ARA), a Canadian medical device company and a leader in optical molecular imaging products for the healthcare and pharmaceutical industries, is pleased to announce that Dr. Gregory Czarnota, MD, PhD, Radiation Oncologist at Odette Cancer Centre, Sunnybrook Health Sciences Centre, will be presenting SoftScan® clinical results from a breast cancer treatment monitoring study, at the IEEE Engineering in Medicine and Biology Society 31st Annual International Conference in Minneapolis, Minn.
A personalized tumor cell vaccine strategy targeting Myc oncogenes combined with checkpoint therapy creates an effective immune response that bypasses antigen selection and immune privilege, according to a pre-clinical study for neuroblastoma and melanoma.
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that Dr. Spyros Kalams will provide an update of interim immune responses and safety results from the HVTN 080 Phase I clinical study of Inovio's PENNVAX-B HIV DNA vaccine in a preventive setting.
› Verified 4 days ago
| Provider Name | Blake Charles Mann |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1104493089 PECOS PAC ID: 7810397635 Enrollment ID: I20210616002159 |
News Archive
Researchers have devised a new plan of attack against a group of deadly childhood brain cancers collectively called diffuse midline gliomas, including diffuse intrinsic pontine glioma, thalamic glioma and spinal cord glioma.
The Queensland Government has tightened pool safety laws and launched a pool safety education campaign. From now on all pool fences will have to comply with new safety requirements within five years. Safety inspections will be required if a property is sold or rented before then. This is the second phase of tough new pool laws. The laws also give safety inspectors greater powers of entry to undertake checks.
ART Advanced Research Technologies Inc. (ART) (TSX:ARA), a Canadian medical device company and a leader in optical molecular imaging products for the healthcare and pharmaceutical industries, is pleased to announce that Dr. Gregory Czarnota, MD, PhD, Radiation Oncologist at Odette Cancer Centre, Sunnybrook Health Sciences Centre, will be presenting SoftScan® clinical results from a breast cancer treatment monitoring study, at the IEEE Engineering in Medicine and Biology Society 31st Annual International Conference in Minneapolis, Minn.
A personalized tumor cell vaccine strategy targeting Myc oncogenes combined with checkpoint therapy creates an effective immune response that bypasses antigen selection and immune privilege, according to a pre-clinical study for neuroblastoma and melanoma.
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that Dr. Spyros Kalams will provide an update of interim immune responses and safety results from the HVTN 080 Phase I clinical study of Inovio's PENNVAX-B HIV DNA vaccine in a preventive setting.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Performance Enhancement Professionals Llc 71 Mcbry Dr, Dover, DE 19901-4407 Ph: (302) 423-0236 | Performance Enhancement Professionals Llc 1255 S State St, Suite 7, Dover, DE 19901-6932 Ph: (302) 423-0236 |
News Archive
Researchers have devised a new plan of attack against a group of deadly childhood brain cancers collectively called diffuse midline gliomas, including diffuse intrinsic pontine glioma, thalamic glioma and spinal cord glioma.
The Queensland Government has tightened pool safety laws and launched a pool safety education campaign. From now on all pool fences will have to comply with new safety requirements within five years. Safety inspections will be required if a property is sold or rented before then. This is the second phase of tough new pool laws. The laws also give safety inspectors greater powers of entry to undertake checks.
ART Advanced Research Technologies Inc. (ART) (TSX:ARA), a Canadian medical device company and a leader in optical molecular imaging products for the healthcare and pharmaceutical industries, is pleased to announce that Dr. Gregory Czarnota, MD, PhD, Radiation Oncologist at Odette Cancer Centre, Sunnybrook Health Sciences Centre, will be presenting SoftScan® clinical results from a breast cancer treatment monitoring study, at the IEEE Engineering in Medicine and Biology Society 31st Annual International Conference in Minneapolis, Minn.
A personalized tumor cell vaccine strategy targeting Myc oncogenes combined with checkpoint therapy creates an effective immune response that bypasses antigen selection and immune privilege, according to a pre-clinical study for neuroblastoma and melanoma.
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that Dr. Spyros Kalams will provide an update of interim immune responses and safety results from the HVTN 080 Phase I clinical study of Inovio's PENNVAX-B HIV DNA vaccine in a preventive setting.
› Verified 4 days ago
Adrianne Greene, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1288 S Governors Ave, Dover, DE 19904 Phone: 302-677-0100 Fax: 302-677-0267 | |
Ms. Amy Kathryn Tullis, PT, MPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 97 Commerce Way, Suite 101, Dover, DE 19904 Phone: 302-734-8000 | |
Jihwan Jeong, Physical Therapist Medicare: Medicare Enrolled Practice Location: 1288 S Governors Ave, Dover, DE 19904 Phone: 302-677-0100 | |
Matthew Vassalotti, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1288 S Governors Ave, Dover, DE 19904 Phone: 302-677-0100 Fax: 302-677-0267 | |
Kathy Tompkins, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 945 Forest St, Dover, DE 19904 Phone: 302-672-1500 | |
Christine Marie Reynolds, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1203 Walker Rd, Dover, DE 19904 Phone: 302-735-8800 | |
Katherine Marie Monahan, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1288 S Governors Ave, Dover, DE 19904 Phone: 302-677-0100 |